🔎 Trials Near Me

Utama › Sklerosis Pelbagai › California

Kajian klinikal Sklerosis Pelbagai di California

24 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Fresno
  • TG Therapeutics Investigational Trial Site, Newport Beach
  • TG Therapeutics Investigational Trial Site, Orange
  • dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • UC San Diego, La Jolla
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07477639

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Kadima Neuropsychiatry Institute, San Diego
  • Providence Medical Foundation, Santa Rosa
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Private Practice - Dr. Regina Berkovich- Site Number : 8400005, West Hollywood
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • Local Institution - 0114, Loma Linda
  • University of California Davis Health, Sacramento
Mengambil pesertaFasa 3
Umur 10 hingga 17 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06408259

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, La Jolla
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06680037

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford Neuroscience Health Center, Palo Alto
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT07304154

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

  • University of California-San Francisco, San Francisco
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Wanita · Dikemas kini 11 Ogo 2026 · NCT06940323

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Fullerton Neuro and Headache Ctr, Fullerton
  • Regina Berkovich MD PhD Inc, West Hollywood
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07225504

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

  • Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
Mengambil pesertaFasa 1/2
Umur 18 hingga 55 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05359653

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

  • Byers Hall, San Francisco
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT07510607

ECoG BMI for Motor and Speech Control

  • University of California San Francisco, San Francisco
Mengambil peserta
Umur 21 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT03698149

Care in Multiple Sclerosis (MS)

  • University of California, San Francisco, San Francisco
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT07011914

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

  • Stanford University, Redwood City
Mengambil pesertaFasa 1
Umur 18 hingga 60 · Semua jantina · Dikemas kini 23 Mac 2026 · NCT07139743

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • University of California San Francisco, San Francisco
Mengambil pesertaFasa 2
Umur 18 hingga 55 · Semua jantina · Dikemas kini 11 Mac 2026 · NCT02521311

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

  • Stanford Multiple Sclerosis Center, Palo Alto
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 27 Feb 2026 · NCT06138132

Central Vein Sign in Multiple Sclerosis Extension Study

  • Cedars-Sinai Medical Center, Los Angeles
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 20 Feb 2026 · NCT07424027

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

  • University of California, San Francisco, San Francisco
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Okt 2025 · NCT07222618

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

  • UCSF, San Francisco
  • Stanford University, Stanford
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Mei 2025 · NCT05395624

Kesimpta (Ofatumumab) Pregnancy Registry

  • University of California San Diego OTIS, La Jolla
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 14 Jan 2025 · NCT05634967

Entire-body PET Scans for Multiple Sclerosis

  • Brain Health Alliance, Ladera Ranch
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
Umur 25 hingga 55 · Semua jantina · Dikemas kini 7 Jan 2025 · NCT04390009

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

  • Novartis Investigative Site, La Jolla
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Wanita · Dikemas kini 16 Mei 2024 · NCT04933552

MS-ResearchBiomarkerS

  • Cedars-Sinai Medical Center, Los Angeles
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukanMenyebut bayaran untuk peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Feb 2024 · NCT05204459

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.